Edition:
United States

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

116.92USD
9 Dec 2016
Change (% chg)

$-1.16 (-0.98%)
Prev Close
$118.08
Open
$118.76
Day's High
$118.76
Day's Low
$116.42
Volume
118,464
Avg. Vol
169,980
52-wk High
$132.95
52-wk Low
$67.81

Summary

Name Age Since Current Position

Michael Minogue

49 2005 Chairman of the Board, President, Chief Executive Officer

Michael Tomsicek

50 2015 Chief Financial Officer, Vice President, Treasurer

David Weber

54 2007 Chief Operating Officer

William Bolt

64 2011 Senior Vice President - Global Product Operations

Andrew Greenfield

43 2014 Vice President, General Manager - Global Marketing

Michael Howley

52 2009 Vice President, General Manager - Global Sales and Marketing

Dorothy Puhy

64 2005 Lead Independent Director

Jeannine Rivet

68 2016 Director

Christopher Van Gorder

63 2016 Director

Eric Rose

65 2014 Independent Director

Martin Sutter

61 2008 Independent Director

Henri Termeer

70 1987 Independent Director

Paul Thomas

60 2011 Independent Director

Biographies

Name Description

Michael Minogue

Mr. Michael R. Minogue is Chairman of the Board, President, Chief Executive Officer of Abiomed, Inc. In June 2005, he was appointed Chairman of our Board of Directors. Prior to joining us, Mr. Minogue had a twelve-year career at General Electric, or GE. Most recently, Mr. Minogue was Vice President and General Manager of Americas Sales and Marketing for GE Medical Systems Information Technology. From 1997 to 2004, Mr. Minogue held various positions at GE, including General Manager for the Global Positron Emission Technology Business, General Manager, Americas Cardiology & IT Sales and General Manager, Global Installed Base. Prior to joining GE, Mr. Minogue served on active duty for four years as an infantry officer in the U.S. Army and received multiple awards. Mr. Minogue received his Bachelor of Science in Engineering Management from the United States Military Academy at West Point and his Master of Business Administration from the University of Chicago. Mr. Minogue currently serves on the Board of Directors of the Advanced Medical Technology Association and also serves as a Manager on the Board of Managers of Bioventus LLC, a strategic partnership between Essex Woodlands and Smith & Nephew plc, a global medical technology business based in the United Kingdom. Mr. Minogue is also the Chair of the Board of Directors of the Medical Device Innovation Consortium, a public-private partnership created with the objective of advancing medical device regulatory science. He was formerly our designee on the Board of Directors of World Heart Corporation, and was formerly on the Board of Directors of LifeCell Corporation, which was acquired by Kinetic Concepts, Inc. in May 2008. Mr. Minogue has leadership, his management abilities and experience, and his extensive knowledge of our industry gained from his senior executive roles.

Michael Tomsicek

Mr. Michael Tomsicek is Chief Financial Officer, Vice President and Treasurer of Abiomed, Inc. and served as Senior Vice President and Chief Financial Officer of Cubist Pharmaceuticals, Inc. (“Cubist”) from March 2013 until January 2015. From July 2012 until March 2013, Mr. Tomsicek served as Cubist’s Senior Vice President and Deputy Financial Officer and from August 2010 to July 2012, he was Cubist’s Vice President of Corporate Finance and Treasurer. Before joining Cubist, Mr. Tomsicek served for eight years holding roles with increasing influence within the Healthcare unit of General Electric (“GE”). His service at GE culminated in his role first as Chief Financial Officer of the Diagnostic Ultrasound business and finally Chief Financial Officer of the Global Ultrasound product group. Prior to that, Mr. Tomsicek was Manufacturing Finance Manager for the GE Healthcare Monitoring Systems business and was selected to and completed the GE Experienced Financial Leadership Program. Mr. Tomsicek also held various advancing roles in financial planning and channel management over seven years in the automotive division of Motorola, then a public global telecommunications company. Following graduation from the University of Wisconsin with a BS in Industrial Engineering, Mr. Tomsicek began his career in manufacturing consulting for a Boston area start up after which he received his M.B.A., also from the University of Wisconsin.

David Weber

Dr. David M. Weber is Chief Operating Officer of Abiomed, Inc., since April, 2007. Prior to joining the company, Dr. Weber served as General Manager, Aviation Business at GE Security—Homeland Protection from April 2005 until April 2007 where he led GE Security’s Aviation and Transportation Business and was responsible for product development, marketing and sales. From June 2004 until April 2005, he served as General Manager, MRI Marketing at GE Healthcare where he was responsible for strategic product planning, go-to-market and product launch activities including developing product roadmaps and introducing new product technologies to the market, and from March 2001 until June 2004, he served as Manager, Global High Field MRI Business, GE Medical Systems where he was responsible for new product planning and development. Dr. Weber has a Bachelor of Science in physics from Denison University, a Bachelor of Science in Nuclear Engineering from Columbia University, a Master of Science in Medical Physics from the University of Wisconsin—Madison, and a Doctor of Philosophy in Medical Physics from the University of Wisconsin—Madison.

William Bolt

Mr. William J. Bolt is Senior Vice President - Global Product Operations of Abiomed, Inc. He is currently responsible for all product development, management, engineering, regulatory and quality functions. From 2006 to 2009 he was responsible, at different times, for quality regulatory and engineering functions. From 2003 to 2006 he was responsible for quality and service functions. He was responsible for all product development and the AbioCor program from 2000-2003, and for BVS and AB5000 development from 1999-2003. From 1994 to 1999, he was President of former dental subsidiary, ABIODENT. From 1982 to 1994, he served in various roles, from Vice President of Engineering to Vice President of Operations. Mr. Bolt received both his Bachelor of Science in Electrical Engineering and Master of Business Administration from Northeastern University.

Andrew Greenfield

Mr. Andrew J. Greenfield is Vice President, General Manager - Global Marketing of Abiomed, Inc., serves as our Vice President and General Manager of Global Marketing. Prior to joining us, Mr. Greenfield held multiple positions at GE Healthcare since October 1999, including consulting with large U.S. health systems in the Enterprise Client Group from November 2003 to January 2005, Six Sigma Master Black Belt from January 2002 to November 2003, and Finance Manager from October 1999 to January 2002. Prior to GE Healthcare, he held multiple positions in marketing and sales management at the Boeing Company, including Project Manager and European Country Manager. He received his Bachelor of Science in Finance from the University of Illinois and his Master of Business Administration from St. Louis University. Mr. Greenfield is also a certified Master Blackbelt in Six Sigma and Change Acceleration Process from GE.

Michael Howley

Mr. Michael G. Howley is Vice President, General Manager - Global Sales and Marketing of Abiomed, Inc., since March, 2009. Prior to joining the company, Mr. Howley spent 20 years at GE Healthcare. From February 2006 to February 2009, he was General Manager at GE Healthcare, overseeing the Americas X-ray and Interventional Radiology division. From April 2004 to February 2006, Mr. Howley held the General Manager position for the Clinical Information Systems at GE. From October 2002 to April 2004, he was the Americas Sales Manager of Functional and Molecular Imaging. Prior to this role, Mr. Howley held several other national and regional sales positions at GE, beginning his tenure with the company in 1989. Mr. Howley has a Bachelor of Science in Business Administration and Marketing from Auburn University.

Dorothy Puhy

Ms. Dorothy E. Puhy is Lead Independent Director of Abiomed, Inc. Ms. Puhy has served as a director since August 2003 and as Lead Director since October 2005. Ms. Puhy has served as Executive Vice President and Chief Operating Officer for the Dana-Farber Cancer Institute since 2012. Ms. Puhy previously served as the Chief Financial Officer of Dana-Farber from 1994 to 2012 and as its Assistant Treasurer from 1995 to 2012. From 1985 to 1994 Ms. Puhy held various financial positions at the New England Medical Center Hospitals, Inc., including Chief Financial Officer from 1989 to 1994. Ms. Puhy is also a director of Eaton Vance Corp. Ms. Puhy received her Bachelor of Arts from the University of Pennsylvania and her Master of Business Administration from the Wharton School of Business at the University of Pennsylvania. Ms. Puhy has extensive industry knowledge, her financial acumen, her executive level experience at a major medical research institute and her extensive industry knowledge.

Jeannine Rivet

Ms. Jeannine M. Rivet is Director of Abiomed, Inc., Ms. Rivet is Executive Vice President of UnitedHealth Group, the most diversified healthcare company in the U.S. In her role, Ms. Rivet works with and on behalf of all business segments in areas focused on strategic business relationships, customer relations, and clinical advancement. Previous roles at UnitedHealth Group include Chief Executive Officer of UnitedHealthcare, Chief Executive Officer of Ingenix and Chief Executive Officer of Optum. Ms. Rivet is a driving force in challenging the industry to enhance health and well-being through information, collaboration and advancement of optimal health care. Ms. Rivet is on the executive leadership team of UnitedHealth Group and on numerous industry leadership boards and councils, as well as a mentor to women in business. She has been recognized by AAHP, Boston University School of Public Health, Fortune magazine, Girl Scouts of Minnesota and Wisconsin River Valleys, Minneapolis St. Paul Business Journal and Minnesota's City Business and was inducted as a fellow into the American Academy of Nursing. Ms. Rivet received her master's degree in Public Health from Boston University. She also holds a bachelor's degree in nursing from Boston College and was a registered nurse for several years prior to entering the managed care business.

Christopher Van Gorder

Mr. Christopher D. Van Gorder is Director of Abiomed, Inc. Mr. Van Gorder has been president and Chief Executive Officer of Scripps Health since 2000, where he has been instrumental in positioning Scripps among the nation's foremost health care institutions. At Scripps Health, Mr. Van Gorder oversees all functions of the integrated health system that has 15,000 employees and 2,600 affiliated physicians, including its five acute-care hospital campuses, dozens of outpatient centers throughout San Diego County, and a regional home health service and hospice. In March 2006, California's governor appointed Mr. Van Gorder, a former police officer, to the California Commission on Emergency Medical Services (EMSA) where he served two terms. In January 2007, U.S. Secretary of State Condoleezza Rice reappointed Mr. Van Gorder to the U.S. Commission for the United Nations Educational, Scientific and Cultural Organization (UNESCO). He is a clinical professor of health practice at the University of Southern California (USC) Price School of Public Policy, where he also serves on the Board of Councilors. Mr. Van Gorder received his master's degree in public administration/health services administration at the University of Southern California, completed the Wharton CEO Program at the University of Pennsylvania and earned his bachelor's degree from California State University, Los Angeles.

Eric Rose

Dr. Eric A. Rose, M.D., Class II., is an Independent Director of Abiomed, Inc.. Dr. Rose has been serving since March 2007 as Executive Vice President for Life Sciences at MacAndrews & Forbes and Chief Executive Officer of Siga Technologies, Inc., a developer of anti-viral drugs directed at potential agents of bioterror. From 1994 to 2007, he was Surgeon in Chief at New York-Presbyterian Hospital/Columbia and Chairman of the Department of Surgery at the Columbia University College of Physicians and Surgeons. A heart surgeon, researcher and entrepreneur, Dr. Rose has helped grow Columbia’s Department of Surgery over the past 25 years while investigating, managing and developing complex medical technologies such as technologies for heart transplantation and new approaches to Alzheimer’s disease and bioterrorism. He has authored or co-authored more than 300 scientific publications and has received more than $25 million in NIH support for his research. Dr. Rose pioneered heart transplantation in children, performing the first pediatric heart transplant in 1984, and has investigated many alternatives to heart transplantation, including cross-species transplantation and man-made heart pumps. He received both his undergraduate and medical degrees from Columbia University.

Martin Sutter

Mr. Martin P. Sutter is an Independent Director of Abiomed, Inc., since May 2008. Since 1994, Mr. Sutter has been a managing director of Essex Woodlands Health Ventures, a healthcare focused growth equity firm he co-founded. Mr. Sutter has more than 30 years of management experience in operations, marketing, finance and venture capital. Mr. Sutter currently serves on the Board of Directors of QSpex Technologies, Inc., a manufacturer of prescription spectacle lenses. Mr. Sutter holds a Bachelors of Science from Louisiana State University and a Masters of Business Administration from the University of Houston.

Henri Termeer

Mr. Henri A. Termeer is an Independent Director of Abiomed, Inc., Prior to Genzyme Corporation’s acquisition in April 2011 by Sanofi, Mr. Termeer had been the President, and a director of Genzyme Corporation since 1983, its Chief Executive Officer since 1985 and its Chairman since 1988. Mr. Termeer is a member of the Board of Directors of the Massachusetts Institute of Technology, Massachusetts General Hospital and Partners HealthCare. Mr. Termeer is a member of the Board of Fellows of Harvard Medical School. He is also the Chairman of the Board of Aveo Pharmaceuticals and member of the Board of Directors of Verastem, Inc. Mr. Termeer served as the Deputy Chairman of the Federal Reserve Bank of Boston from 2007 to 2009 and as its Chairman from 2010 through the end of 2011. Mr. Termeer studied economics at the Economische Hogeschool at Erasmus University in The Netherlands and received his Master of Business Administration from the Darden School of Business at the University of Virginia.

Paul Thomas

Mr. Paul G. Thomas is an Independent Director of Abiomed, Inc., Mr. Thomas has been the Chief Executive Officer of Roka Bioscience, Inc. since September 2009. Previously he served as Chairman, Chief Executive Officer, and President of LifeCell Corporation from October 1998 until August 2008. Prior to joining LifeCell, Mr. Thomas held various senior positions during a 15-year tenure with the Pharmaceutical Products division of Ohmeda Inc. Mr. Thomas currently serves on the Board of Directors of Aegerion Pharmaceuticals, Inc. Mr. Thomas received his Bachelor of Science in Chemistry from St. Michael’s College, his Master of Business Administration from Columbia University, and completed his postgraduate studies in chemistry at the University of Georgia. We believe that Mr. Thomas’ extensive leadership experience with companies in the life sciences industry qualifies him to serve as a member of our Board of Directors.

Basic Compensation

Options Compensation